Abbott Laboratories (ABT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ABT Annual Balance Sheets →
A period-by-period view of the balance sheet from Abbott Laboratories to Sep 30 2025 helps clarify how Sep 30 2026's financial structure has changed over time.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ABT/balance-sheets
https://api.csimarket.com/api/v1/companies/ABT/fundamentals
https://api.csimarket.com/api/v1/companies/ABT/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent4,052.00
Short-term Investments, Total246.00
Cash & Short-term Investments4,298.00
Accounts receivable9,032.00
Inventories7,337.00
Other current assets1,730.00
Total Current Assets23,496.00
Equipment/Property/Plant Net26,714.00
Goodwill net32,643.00
Intangible Assets19,591.00
Long-term investments1,099.00
Deferred Income Taxes And Other Assets Noncurrent18,538.00
Inventory Finished Goods Net Of Reserves4,004.00
Inventory Work In Process Net Of Reserves845.00
Inventory Raw Materials Net Of Reserves2,022.00
Prepaid Expense And Other Receivables2,307.00
Total Assets108,247.00
Liabilities
Accounts Payable, Trade, Current4,656.00
Employee-related Liabilities, Current AC1,896.00
Long-term Debt, Current Maturities LO1,708.00
Other current liabilities7,677.00
Accrued Income Taxes, Current TA215.00
Total Current Liabilities16,152.00
Long-term debt29,451.00
Total Long-term Debt29,451.00
Employee benefit plans0.00
Deferred income taxes0.00
Other longterm liabilities11,021.00
Post Employment Obligations Deferred Income Taxes And Other Long Term Liabilities7,038.00
Total Liabilities56,624.00
Stockholders' Equity
Treasury Stock Common Value-15,722.00
Common Stock Value25,645.00
Retained Earnings / Accumulated Deficit49,638.00
Accumulated Other Comprehensive Income-6,343.00
Other Equity-6,343.00
Common Stockholder's Equity51,027.00
Non-controlling interests & other596.00
Total Stockholder's Equity51,623.00
Liabilities & Stockholder's Equity108,247.00
4 historic quarters locked

Sign in to unlock the full Abbott Laboratories balance sheet history.

About Abbott Laboratories Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260930)
  • Filed with the SEC: November 4, 2026
  • Source: abt-20260930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-070154

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI